XML 29 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Related Party Transactions
9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
Related Party Transactions

12. Related Party Transactions

The Amgen Collaboration Agreement expired in September 2024. As of December 31, 2023, the Company was obligated to pay Amgen $3.1 million which was recorded within current liabilities and $6.3 million related to amounts prepayable to Amgen were recorded as prepaid expenses and other current assets on the condensed consolidated balance. During the nine months ended September 30, 2024 and 2023, the Company recorded $12.5 million and $24.4 million respectively, of research and development expenses with Amgen.